MSB 3.19% 97.0¢ mesoblast limited

Great to see results still on track and highlights...

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    Great to see results still on track and highlights mesoblasts/silviu’s strong belief that GvHD approval will still occur post type A meeting and that results will be positive for back pain given the plan for phase 3 confirmatory trial in partnership with gruenenthal, Shane about JCR profits down due to manufacturing facility but we already knew this would happen, bring on the next two weeks of massive announcements!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.